Evidence map›Paper›PMID 41458582›Full record

ArticleHead and Neck Tumor Segmentation for MR-Guided Applications : First MICCAI Challenge, HNTS-MRG 2024, held in conjunction with MICCAI 2024, Marrakesh, Morocco, October 17, 2024, proceedings2025

Ensemble of LinkNet Networks for Head and Neck Tumor Segmentation.

Maria Baldeon-Calisto

Abstract read
In one paragraph

Article in Head and Neck Tumor Segmentation for MR-Guided Applications : First MICCAI Challenge, HNTS-MRG 2024, held in conjunction with MICCAI 2024, Marrakesh, Morocco, October 17, 2024, proceedings, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Overview of the Head and Neck Tumor Segmentation for Magnetic Resonance Guided Applications (HNTS-MRG) 2024 Challenge.Head and Neck Tumor Segmentation for MR-Guided Applications : First MICCAI Challenge, HNTS-MRG 2024, held in conjunction with MICCAI 2024, Marrakesh, Morocco, October 17, 2024, proceedings · 2025
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Maria Baldeon-CalistoDepartamento de Ingeniería Industrial and Instituto de Innovación en Productividad y Logística CATENA-USFQ, Universidad San Francisco de Quito USFQ, Quito, Ecuador.

Funding

Development of functional magnetic resonance imaging-guided adaptive radiotherapy for head and neck cancer patients using novel MR-Linac deviceR01DE028290 · NIDCR · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI CHRISTODOULEAS, JOHN PAUL, FULLER, CLIFTON DAVID · 2019 to 2023
$4.3M
SCH: Personalized Rescheduling of Adaptive Radiation Therapy for Head & Neck CancerR01CA257814 · NCI · RICE UNIVERSITY · PI FULLER, CLIFTON DAVID, SCHAEFER, ANDREW J · 2021 to 2024
$1.8M
NCI NIH HHS R01 CA257814NIDCR NIH HHS R01 DE028290
6 · The paper itself

Abstract

The segmentation of head and neck cancer (HNC) tumors is a critical step in radiotherapy treatment planning. The development of automatic segmentation algorithms has the potential to streamline the radiation oncology process. In this work, we develop an ensemble of LinkNet networks for HNC tumor segmentation as part of the HNTS-MRG 2024 Grand Challenge. A single LinkNet network, pretrained on the Imagenet dataset, was trained for 200 epochs on the HNC dataset provided by the challenge. Eight good performing weights from the internal validation set were selected to create an ensemble of 2D networks. Specifically, each selected weight was used to generate a LinkNet architecture, resulting in eight networks whose predictions were averaged to produce the final predicted segmentation. Our experiments demonstrate that the ensemble network performs better than each individual architecture, leveraging the benefits of ensemble learning without the computational cost of training each network from scratch. In the challenge's test set, the LinkNet Ensemble (team ECU) achieved an aggregated Dice score of 64.60% and 49.53% for metastatic lymph nodes and primary gross tumor segmentation, respectively, and a mean score of 57.06%.

Indexed as

Convolutional Neural NetworksDeep LearningHead and Neck CancerTumor Segmentation

Identifiers

PMID41458582
PMCPMC12742962

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.